Crossmark

Treatment of tuberous sclerosis complex manifestations in children with mTOR inhibitors

Crossref DOI link: https://doi.org/10.1007/s00381-023-06218-2

Published Online: 2023-11-10

Published Print: 2024-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yeşil, Şule https://orcid.org/0000-0002-2328-8612
Kurucu, Burçak https://orcid.org/0000-0003-3474-5070
Hamamcı, Melda Berber https://orcid.org/0000-0001-6875-5766
Yılmaz, Şükriye https://orcid.org/0000-0002-5777-6147
Şahin, Gürses https://orcid.org/0000-0002-8569-3971
License Information

Text and Data Mining valid from 2023-11-10

Version of Record valid from 2023-11-10
More Information

Article History

Received: 16 October 2023

Accepted: 6 November 2023

First Online: 10 November 2023

Declarations

:

: The authors declare no competing interests.